 3. Female patients must be either postmenopausal for at least 1 year, surgically incapable of childbearing, or effectively practicing an acceptable method of contraception oralparenteralimplantable hormonal contraceptives, Intrauterine Device IUD, or barrier and spermicide. Abstinence only is not an acceptable method. Patients must agree to use adequate contraception during the study and for 4 weeks after their last dose of corticotrophin ACTH. Male patients must agree to ensure they or their female partners are using adequate contraception during the study and for 4 weeks after the patient receives their last dose of corticotrophin ACTH. 